Holen Sie sich die Stockscreener-App
1.81
0.83%
0.01
Serina Therapeutics Inc Aktie (SER) Neueste Nachrichten
Sio Capital (SER) reports 1,000,000 shares, 6.71% stake in Serina Therapeutics - Stock Titan
Serina Therapeutics (SER) Stock: Is It a Strong Investment Pick | Q4 2025: Earnings Beat EstimatesTrending Entry Points - Newser
SER Stock Price, Quote & Chart | SERINA THERAPEUTICS INC. (NYSEARCA:SER) - ChartMill
Chart Pattern Insight | Serina Therapeutics notches 33% EPS beat, tops loss estimatesPost Earnings - Newser
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (NYSE: SER) seeks share increase and equity plan changes in 2026 proxy - Stock Titan
Serina Therapeutics Updates Executive Leadership and Governance Structure - The Globe and Mail
Serina Therapeutics Appoints New CTO, Increases CEO Salary, and Amends Bylaws in April 2026 - Minichart
Serina Therapeutics promotes Srini Tenjarla to CTO and updates company bylaws By Investing.com - Investing.com South Africa
Serina Therapeutics promotes Srini Tenjarla to CTO and updates company bylaws - Investing.com Australia
Executive pay changes and new CTO at Serina Therapeutics (NYSE: SER) - Stock Titan
Serina Therapeutics (SER) director granted 59,667 dividend shares - Stock Titan
Director at Serina Therapeutics (SER) receives 7,553 share grant - Stock Titan
Serina names Srini Tenjarla CTO; raises CEO Steve Ledger's salary - TradingView
Serina Therapeutics, Inc. (SER) - Minichart
Share increase to 125M, 2M-plan reserve sought by Serina (NYSE: SER) - Stock Titan
Market Review: What is the dividend yield of Serina Therapeutics IncWeekly Trend Recap & Verified Momentum Stock Alerts - baoquankhu1.vn
Take Profit: What is the dividend yield of Serina Therapeutics IncMarket Growth Report & Free High Return Stock Watch Alerts - baoquankhu1.vn
Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit - Sahm
Serina Therapeutics, Inc Announces Novel Lipid Nanoparticles Built On POZ Platform - marketscreener.com
Recap Report: Will PHUN be affected by tariffs2026 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn
Serina says its nanoparticle polymer avoided antibodies in rat study - Stock Titan
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - Sahm
Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set - MSN
Serina Therapeutics announces NYSE American acceptance of continued listing compliance plan - marketscreener.com
Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan - TradingView
SER Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Serina Therapeutics (SER) files 10-K amendment to correct auditor consent - stocktitan.net
New funding to support Serina’s SER-252 trial in advanced Parkinson’s - Parkinson's News Today
SER Stock Price and Chart — AMEX:SER - TradingView
Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart
Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan
[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan
Serina Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks
Serina Therapeutics CSO Moreadith sells $18,567 in stock - Investing.com
Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart
Serina Therapeutics to Present at 38th Annual Roth Conference - National Today
Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget
Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - MarketScreener
Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView — Track All Markets
Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan
Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade
0.78%
3.01%
Kapitalisierung:
|
Volumen (24h):